Ciclib 125mg Palbociclib Capsule

Ciclib 125mg Palbociclib Capsule is a prescription targeted anti-cancer medication used in the treatment of hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer. It contains Palbociclib, a CDK4/6 inhibitor that works by blocking proteins involved in cancer cell growth and division. By slowing the progression of cancer cells, Ciclib 125mg Capsule helps improve treatment outcomes when used in combination with hormone therapy. Taken orally under the guidance of an oncology specialist, it is commonly prescribed as part of a comprehensive breast cancer treatment plan. Regular monitoring of blood cell counts and overall health is important during therapy to assess effectiveness and manage potential side effects. Patients should use Ciclib 125mg Palbociclib Capsule only as directed by their healthcare provider.